Detalles de la búsqueda
1.
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Springerplus
; 3: 244, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24860718
2.
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.
J Clin Oncol
; 29(33): 4394-400, 2011 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21969495
3.
A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01).
Clin Breast Cancer
; 10(4): 307-12, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20705564
4.
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.
J Clin Oncol
; 27(5): 672-80, 2009 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19114685
5.
Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature.
Arch Pathol Lab Med
; 127(7): 865-7, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12823044
Resultados
1 -
5
de 5
1
Próxima >
>>